CGM Without Diabetes: What 14 Days of Glucose Data Reveal

For most adults, the entire assessment of their glucose metabolism consists of one number, drawn once a year, after an overnight fast — a state that resembles almost nothing about how they actually live. That number comes back normal in the large majority of people, including many who are already several years into the process that ends in type 2 diabetes. Continuous glucose monitoring in people without diabetes is an attempt to close that gap: to replace a single snapshot taken under artificial conditions with two weeks of data collected during ordinary meals, ordinary sleep, and ordinary stress.

It is also one of the more oversold tools in consumer health. Sensors are sold directly to the public alongside apps that grade meals and assign scores, and the food anxiety this produces is a real clinical problem rather than a theoretical one. Both things are true at once: the data is genuinely informative, and the interpretation most people receive with it is not. What follows is what the measurement shows, what drives the numbers, and where the evidence runs out.

Why fasting glucose is a late signal

Type 2 diabetes does not begin on the day a fasting glucose crosses 126 mg/dL. Insulin resistance comes first: muscle and liver respond less efficiently to insulin, the pancreas compensates by secreting more of it, and blood glucose stays normal precisely because the beta cells are working harder to keep it there. That compensation can hold for years. Throughout it, the fasting glucose is unremarkable and the patient is told their sugar is fine.

What fails first is not the fasting state but the fed state. The earliest reliably measurable abnormality in most people is a higher, longer rise after eating — the system still returns to baseline, but it overshoots further and takes longer to get back. Fasting glucose drifts up later. HbA1c, an average over roughly three months, can absorb a great many post-meal excursions without moving appreciably. Long-running cohorts that followed people through to a diabetes diagnosis have described the same shape repeatedly: years of near-flat conventional markers, then a steep rise in the short window before the diagnostic threshold is crossed. By the time the standard tests move, a substantial portion of beta-cell function is already lost.

What continuous glucose monitoring actually measures

A CGM sensor sits in subcutaneous tissue and samples glucose in interstitial fluid — not blood — every few minutes for ten to fourteen days. The value displayed is therefore a smoothed, slightly delayed estimate of blood glucose, typically trailing it by several minutes, most noticeably when glucose is changing fast. This is a real limitation, but it is the wrong thing to fixate on, because the point of the method is not any individual reading. It is the shape of several hundred readings a day, recorded while you are living your life rather than sitting in a phlebotomy chair.

Four features of that curve carry most of the clinical information: where the overnight baseline sits, how high and how long the post-meal excursions run, what proportion of the day is spent inside a normal band, and how much the whole trace swings around its own mean.

Note what is missing from that list: insulin. CGM measures the outcome of the glucose–insulin system, not the effort required to produce it. Someone in the compensated phase of insulin resistance can hold a respectable-looking trace while running very high insulin levels to do it. This is the single most important reason CGM should not be interpreted alone.

The same meal does different things to different people

The most robust finding to come out of this field — established most influentially by the personalised-nutrition work done at the Weizmann Institute — is that post-meal glucose responses to identical foods vary enormously between individuals. The same bread, eaten in the same quantity, produces a modest bump in one person and a sustained excursion in another. This holds even between people whose fasting glucose and HbA1c are indistinguishable, which is why generic glycemic-index tables predict individual responses poorly.

The variation is not mystical. Most of it is accounted for by factors that are, in principle, observable:

• Meal composition — the same carbohydrate eaten with protein, fat, or fibre produces a slower, lower rise than the carbohydrate alone.
• Order of eating — small studies have repeatedly found that eating vegetables and protein before the starch component blunts the excursion that follows.
• Sleep — experimental sleep restriction reliably reduces insulin sensitivity in healthy volunteers, and the effect shows up the very next morning.
• Activity timing — muscle takes up glucose in a partly insulin-independent way during contraction, so movement close to a meal changes that meal's curve.
• Stress and illness — cortisol and adrenaline raise glucose directly, independent of anything eaten.
• Individual physiology — baseline insulin sensitivity, gastric emptying rate, body composition, and gut microbial composition all contribute.

The patterns people actually discover

In practice, two weeks of monitoring tends to surface a small number of specific, personally relevant findings rather than a general verdict on someone's diet. The recurring ones are worth naming, because they are the reason the exercise is often worth doing at all.

The most common is the ostensibly healthy breakfast — the granola, the fruit smoothie, the low-fat yoghurt with honey, the rice cake — producing the largest excursion of the day, frequently followed by a rapid fall and the mid-morning hunger that comes with it. A second is the post-meal walk: ten to twenty minutes of easy movement after eating visibly flattens the curve, and it is one of the few interventions where the effect is immediate and unambiguous on the trace. A third is the cost of one poor night of sleep, which can raise the response to a familiar breakfast enough that people initially assume the sensor has failed. A fourth is the effect of a late, large dinner on the overnight baseline, which otherwise ought to be flat.

The useful output of two weeks of monitoring is almost never a list of forbidden foods. It is a short list of personal levers: what you eat alongside what, in what order, and what you do in the twenty minutes afterwards.

The limitations, stated honestly

The case against casual use is stronger than most sellers of these devices acknowledge, and it should be understood before anyone puts on a sensor.

• Glucose excursions after meals are normal physiology. A rise after eating is what a functioning system does. Consumer apps that flag any rise as a "spike" are pathologising a healthy response.
• The anxiety is real. In people prone to it, continuous feedback on food can slide into restriction, avoidance of entire food groups, and a fixation on the trace that does more harm than the numbers ever justified. This is a genuine reason not to hand a sensor to some patients.
• Sensor accuracy has limits. Modern sensors are good but not laboratory-grade; individual readings can deviate meaningfully, compression during sleep produces artefactual lows, and the first day after insertion is often the least reliable.
• The outcome evidence is still emerging. That CGM changes behaviour in people without diabetes is reasonably well supported. That CGM-guided behaviour change improves hard outcomes — diabetes incidence, cardiovascular events, mortality — in otherwise healthy people has not been demonstrated. Anyone claiming otherwise is ahead of the data.
• Interpretation without clinical context is the main risk. Most of the questionable decisions we see — unnecessary carbohydrate elimination, undereating, conclusions drawn from a single anomalous day — come from reading the app rather than reading the patient.

How it should be used clinically

Used properly, CGM in a person without diabetes is a time-limited diagnostic, not a permanent gadget. A single ten-to-fourteen-day wear, during a representative stretch of normal life, answers the questions worth asking: is the overnight baseline where it should be, do meals return to baseline in reasonable time, is there a specific recurring pattern worth changing, and does the trace suggest early loss of glucose control that the annual bloodwork has not yet registered.

That trace should never be read in isolation. It belongs alongside a fasting insulin — which tells you how much effort the normal-looking glucose is costing — an HbA1c, a fasting glucose, and, where the picture is ambiguous, a formal oral glucose tolerance test with insulin measured alongside glucose. Together these separate the person whose metabolism is genuinely intact from the person maintaining a normal glucose at a high and unsustainable insulin price.

What to ask your physician

If you are considering continuous glucose monitoring and you do not have diabetes, four questions will keep the exercise useful:

• What specific question is this answering? If there is no question, the sensor will generate data rather than information.
• What is my fasting insulin? Ask for it with your next fasting panel, measured alongside glucose so insulin resistance can be assessed. It is the context CGM cannot supply.
• Who is interpreting the data? Agree in advance that a physician reviews the full fourteen days with you, rather than the app grading meals in real time.
• When does it come off? Set the end date before you start, and define what a repeat — if any — would be for.

The argument for measuring glucose continuously is not that post-meal rises are dangerous. It is that metabolic disease develops quietly, over years, in a part of the day that annual bloodwork never observes. Looking there earlier is reasonable. Concluding too much from what you see is not.